Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr^−/− mice

Medicine and Dentistry

• Epoxide Hydrolase 100%
• Monocyte 80%
• LDL Receptor 40%
• Epoxyicosatrienoic Acid 40%
• Depletion 30%
• Gene 30%
• Bone Marrow 30%
• Macrophage 30%
• Atherogenesis 30%
• Lesion 20%
• Diet Types 20%
• Atherosclerosis 20%
• Metabolite 10%
• Endothelial Cell 10%
• Tumor Necrosis Factor 10%
• Cholesterol 10%
• Hyperlipidemia 10%
• Peripheral Blood Mononuclear Cell 10%
• PADGEM Protein 10%
• Plaque 10%
• Antiinflammatory Activity 10%
• Arteriosclerosis 10%
• Artery Wall 10%
• Hydrolase Inhibitor 10%
• Spleen 10%
• Blood 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Epoxide Hydrolase 100%
• Mouse 70%
• Epoxyicosatrienoic Acid 40%
• Low Density Lipoprotein Receptor 40%
• Knockout Mouse 30%
• Atherogenesis 30%
• Atherosclerosis 20%
• P Selectin Glycoprotein Ligand 1 20%
• Cholesterol 10%
• Hyperlipidemia 10%
• Tumor Necrosis Factor 10%
• Inflammatory Disease 10%
• Arachidonic Acid 10%
• Hydrolase Inhibitor 10%
• P-Selectin 10%
• Arteriosclerosis 10%